NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nanjing Shineking Biotech Co., Ltd.

Nanjing Shineking Biotech Co., Ltd.

Private
NanjingFrontier & Industrial Techhttp://www.bioshineking.com/

Last Round

Series B

Extension

Sep 1, 2021

Est. Valuation

$29.85M

Total Funding Raised

$11.4M

Company Overview

Nanjing Shineking Biotech Co., Ltd. is a biotechnology company that develops and manufactures biopolymers, such as poly-amino acids and sugar alcohols, for use in the cosmetic, agricultural, food, and pharmaceutical industries.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Advanced Materials, Sustainable Materials, Fashion & Beauty

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

gamma-polyglutamic acidgamma-PGAbiopolymermicrobial fermentationbiotech manufacturingepsilon-polylysineagricultural biostimulantskincare humectantbio-based materialsagricultural chitosangreen chemistrybiological preservativespecialty chemicalssustainable ingredientsagritech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nanjing Shineking Biotech Co., Ltd. Comparables

Compare Nanjing Shineking Biotech Co., Ltd. with similar companies based on industry and business-model similarity.

Nanjing Shineking Biotech Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Wuhan Guanghua Times Biotechnology Co., Ltd.
80%
Qingdao Bozhi Huili Biotechnology Co., Ltd.
78%
Wei Chuan Foods Corp
76%

Nanjing Shineking Biotech Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionSep 1, 2021
Series BJul 30, 2020
Series A ExtensionDec 1, 2017
Series AAug 1, 2017
AngelDec 1, 2015

Nanjing Shineking Biotech Co., Ltd. Investors

Notable investors and investment history

Nanjing Shineking Biotech Co., Ltd. investors
InvestorRounds
Yuanhe CapitalSeries B Extension
金雨茂物投资管理股份有限公司Angel, Series A, Series B
南京市创新投资集团有限责任公司Series B
Jiangsu Tianyou Investment ManagementSeries B, Series B Extension
Zhejiang Juesheng Investment ManagementSeries B
Addor CapitalSeries B
Ennovation VenturesSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 20, 2024

    Monthly visitors increased 111% MoM.

  • Dec 1, 2015

    Raised an Angel round with investment from 金雨茂物投资管理股份有限公司.

Nanjing Shineking Biotech Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nanjing Shineking Biotech Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nanjing Shineking Biotech Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNanjing
Employee Range3
Year Founded2010
Last FundingSep 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.